1. 1. Dorr, R.T. and Von- Huff, D.D. (1994) Drug monographs. In: Dorr, R.T. and Von-Huff, D.D., (eds.). Cancer chemotherapy handbook, Appleton and Lange, Norwalk, CT, pp. 227–236.
2. 2. Berger R.M., Projan S.J., Horwitz S.B., and Peisach J. (1986) The DNA cleavage mechanism of iron-bleomycin. J. Biol. Chem. 261, 15955–15959.
3. Perry M. (ed.) (2001) The chemotherapy source book. Lippincott Williams & Wilkins, Philadelphia, PA.
4. Chabner B.A. and Longo D.L. (eds.) (2001) Cancer chemotherapy and biotherapy. Lippincott, Williams, and Wilkins, Philadelphia, PA.
5. 5. Poddevin B., Orlowski S., Belehradek, J., Jr., and Mir L.M. (1991) Very high toxicity of bleomycin introduced into the cytosol of cells in culture. Biochem. Pharmacol. 42, S67–S75.